Another phase 0 study has evaluated a potential treatment for GBM with the use of RNA-interfering spherical nucleic acids (SNAs), that consist of nuclei of gold nanoparticles covalently bonded to Bcl2L12 siRNA oligonucleotides, that can penetrate the brain. This evidence concerns the gene BCL2L12 and glioblastoma.